Table 5.
List of oral probiotics under clinical trial.
| Sl. no. | Condition | Intervention | Phase | Reference |
|---|---|---|---|---|
| 1. | Asthma | Probiota Bifido (Bifidobacterium) | Not applicable | https://clinicaltrials.gov/ct2/show/record/NCT03157518?term=oral+probiotic&draw=3&rank=2 (accessed on August 2020) |
| 2. | Gingivitis | Probiotic tablet [mixture of Lactobacillus rhamnosus PB01, DSM 14869 and Lactobacillus curvatus EB10, DSM 32307, 1 ∗ 10(9) CFU] | Not applicable | https://clinicaltrials.gov/ct2/show/NCT04071210?term=oral+probiotic&draw=3&rank=3 (accessed on August 2020) |
| 3. | Bacterial vaginosis | Lactobacillus rhamnosus and lactobacillus acidophilus | Not applicable | https://clinicaltrials.gov/ct2/show/NCT03116789?term=oral+probiotic&draw=3&rank=4 (accessed on August 2020) |
| Lactobacillus rhamnosus and Lactobacillus plantarum | ||||
| 4. | Hyperbilirubinemia, neonatal | Lactobacillus salivarius AP-32 | Not applicable | https://clinicaltrials.gov/ct2/show/NCT03876678?term=oral+probiotic&draw=3&rank=5 (accessed on August 2020) |
| Bifidobacterium animalis subspecies lactis CP-9 | ||||
| 5. | Bacterial vaginosis and vaginal candidiasis at pregnancy | L. acidophilus, L. acidophilus, L. paracasei, L. rhamnosus, Streptococcus thermophilus and Bifidobacterium bifidum | Not applicable | https://clinicaltrials.gov/ct2/show/NCT02795845?term=oral+probiotic&draw=3&rank=9 (accessed on August 2020) |
| 6. | Chronic periodontitis | Lactobacillus rhamnosus SP1 | Phase 2 | https://clinicaltrials.gov/ct2/show/NCT02283736?term=oral+probiotic&draw=2&rank=19 (accessed on August 2020) |
| Mucositis oral | Bifidobacterium animalis subsp. lactis | Phase 3 | https://clinicaltrials.gov/ct2/show/NCT04187222?term=oral+probiotic&draw=3&rank=107 (accessed on August 2020) | |
| 7. | Anti-biotic resistance | L. rhamnosus HN001 | Phase 2 | https://clinicaltrials.gov/ct2/show/NCT01321606?term=oral+probiotic&draw=3&rank=109 (accessed on August 2020) |
| 8. | Dental plaque | Lactobacillus reuteri DSM 17938 and PTA 5289 | Phase 2 | https://clinicaltrials.gov/ct2/show/NCT02311218?term=oral+probiotic&draw=3&rank=114 (accessed on August 2020) |
| 9. | Sepsis | Lactobacillus plantarum | Phase 2 | https://clinicaltrials.gov/ct2/show/NCT00518596?term=oral+probiotic&draw=5&rank=142 (accessed on August 2020) |
| 10. | Rhinitis | Lactobacillus paracasei LP-33 | Phase 3 | https://clinicaltrials.gov/ct2/show/NCT01096615?term=oral+probiotic&draw=5&rank=152 (accessed on August 2020) |